TCT-675 Prolonged ischemia, detected by intracoronary electrocardiography, after coronary bifurcation stenting predicts adverse events during mid-term follow-up  by Vassilev, Dobrin et al.
TCT-672
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after Percutaneous Coronary Intervention: Analysis from Japanese
Multicenter Registry
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1Saiseikai Central Hospital, Tokyo, Japan, 2Keio University School of Medicine,
Tokyo, Japan, 3University of Tokyo, Tokyo, Japan
Background: Although the applicability of percutaneous coronary intervention (PCI) to
patients with coronary artery disease (CAD) continues to expand, lesion complexity is
associated with high risk of in-hospital complication. We sought to generate modern PCI
scoring system based on angiographical lesion complexity and assess its effect on
in-hospital compilations for precise risk prediction.
Methods: Data from 3692 PCI patients from September 2008 to August 2011 at 16
hospitals was analyzed. Patients were scored based on lesion complexity defined by
bifurcation, chronic total occlusion (CTO), type C, and left main lesion, along with
presence of acute thrombus in ST-segment elevation myocardial infarction (STEMI)
presentation (1 point for each variable).
Results: In this cohort, the mean age was 67.4910.76 years and 79.5% were male.
About half of the patients (1857, 50.3%) presented with acute coronary syndrome (ACS)
and 2218 (60.1%) underwent PCI for at least one of the complex lesions. The patients in
higher risk score groups were older (p0.001). Importantly, patients with higher risk
score group had significantly higher in-hospital event rate for death, heart failure and
cardiogenic shock (from 0 to 4 risk score; 1.7%, 4.5%, 6.3%, 7.1%, 40%, p0.001),
bleeding (2.5%, 3.4%, 6.8%, 6.6%, 20%, p0.001), post operative myocardial infarction
(1.5%, 3.1%, 3.8%, 3.8%, 10%, p0.04) and reduced- or no-reflow pattern after PCI
(2.0%, 4.5%, 7.4%, 7.1%, 20%, p0.001). Notably, the complexity scoring system was
associated with adverse outcomes after adjustment for known clinical predictors (OR
1.72; p0.001).
Conclusions: The complexity score was cumulatively associated with in-hospital
complication rate and may be used for event prediction in PCI patients. The operator need
to special attention to perform successful PCI for these complex lesions.
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Background: Percutaneous coronary interventions in saphenous vein graft lesions are
associated with less favorable outcomes. Drug-eluting stents have been shown superior to
bare metal stents in many patients and lesion subsets. Evidence from studies evaluating
drug-eluting stents in saphenous vein graft lesions has been conflicting.
Methods: We performed e meta-analysis of randomized trials comparing drug-eluting
stents (DES) with bare metal stents (BMS) in patients undergoing stent implantation in
saphenous vein graft lesions. Four trials with a total population of 812 patients were
identified: 416 were treated with DES and 396 were treated with BMS. Clinical follow-up
varied from 12 to 36 months. Primary end point was need for repeat revascularization.
Other endpoints were mortality, myocardial infarction and stent thrombosis.
Results: Patients undergoing implantation of DES had lower odds of requiring repeat
revascularization procedures (OR 0.51, 95% CI: 0.32 to 0.81, p0.004). On the other
hand, there were no differences between patients treated with DES vs. BMS regarding the
odds of death (OR 0.1.44, 95% CI: 0.38 to 5.46), myocardial infarction (OR 0.81, 95%
CI: 0.26 to 2.52) and stent thrombosis (OR 0.73, 95% CI: 0.11 to 4.83).
Conclusions: In patients undergoing stenting in saphenous vein graft lesions, DES
reduce the need for repeat revascularization procedures while maintaining a comparable
safety profile with BMS.
TCT-674
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Background: The clinical relevance of biomarker elevation after PCI with contemporary
stents is controversial. We therefore examined the 2-year rates of mortality after stenting
from a large pooled experience with the Xience V everolimus-eluting stent (EES) in
randomized trials and registry studies.
Methods: All EES studies were included from which biomarker data (either troponin or
CKMB) were collected routinely within 48 hours post-PCI normalized to the local hospital
reference. Two-year mortality was examined according to peak post-PCI biomarker.
Results: From the SPIRIT III, SPIRIT IV, XIENCE V USA, XIENCE V India, SPIRIT
V Registry and SPIRIT Women Registry (N14897), post-PCI CKMB and/or troponin
data were available in 8,491 and 3,788 pts respectively. Any post-PCI CKMB or troponin
elevation  the upper limits of normal (ULN) occurred in 24.2% and 42.7% of pts
respectively. In the 2 cohorts mortality at 2 years occurred in 245 (2.9%) and 129 (3.4%) of
pts respectively. There was no relationship between any level of CK-MB or troponin elevation
and 2-year mortality (Table). Among the CK-MB cohort, by protocol definition a peri-
procedural Q-wave MI infarction was diagnosed in 19 pts, whereas a non-Q-wave MI
occurred in 209 pts with elevated CKMB level (1x normal). Mortality at 2 years was
markedly increased in pts with Q-wave compared to non-Q-wave MI (21.1% vs. 4.8%
respectively, p0.02).
Conclusions: In this large experience with DES implantation, peri-procedural biomarker
elevation was common after stent implantation but was not associated with 2-year
mortality, unless a new Q-wave MI developed.
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Prolonged ischemia, detected by intracoronary electrocardiography, after coronary
bifurcation stenting predicts adverse events during mid-term follow-up
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Hristo Mateev5, Pavlin Pavlov5, Milena Pehlivanova2,
1National Heart Hospital, Sofia, Bulgaria, 2National Heart Hospital, sofia,
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Administration, Warsaw, Poland, 4CSK MSWiA, Warsaw, Poland, 5National
Cardiology Hospital, Sofia, Europe
Background: There is uncertainty about influence of periprocedural ischemia and
myonecrosis on long-term results of coronary artery bifurcation stenting (PCI). The aim
of the study is to explore the influence of end-procedural ischemia (detected with
intracoronary electrocardiography (icECG)) and post-procedural myonecrosis (troponin
and CK-MB elevation) on revascularization rates (TLR) and cumulative MACEs at 9-12
months after PCI.
Methods: After placement of intracoronary guidewires in main branch (MB) and side
branch (SB) an uninsulated proximal ends of wires were connected to unipolar V leads.
Intracoronary unipolar ECGs (icECG) were recorded before, during and after stent
placement and at the end of procedure. The maximal ST-segment elevation during
intervention and 5 min after the procedure was recorded in SB and MB. The patient
population consists from 86 patients with stable/unstable angina. Provisional T-stenting
was a default strategy.
Results: 67 patients were followed for more than 9 month. 72% were males, age 668,
diabetics 34%; 43% had previous myocardial infarction, 41% previous PCI. 58% had
multivessel disease. The main treated vessel was LAD (72%). True bifurcation lesions
(Medina xx1) were 58%. On icECG the maximal ST-segment elevation was 129 mm
in MB and 87 mm in SB (p.044). At the end procedure 44 patients had residual
ST-segment changes (66%): 7(13%) SB only, 11(21%) MB only, 16(27%) in both,
8(12%) ST depression in SB or MB, 1(1.5%) was with SB ST-depression and MB
ST-elevation, 1(1.5%) with ST-depression in both branches. Changes on icECG have
78% sensitivity, 97% specificity for detection of post-procedural troponin elevation (32,
48%). At 104 months are presented in table.
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TLR 4.3% (1/23) 11.4% (5/44) .046
MACE 8.7% (2/23) 19% (8/44) .042
Multivariate, proportional hazards Cox multiple regression model





HR  1.469; CI 1.035-2.086 .032
CK-MB elevation
3xN
HR  2.4; CI 1.139-5.057 .021
Conclusions: The intracoronary ECG is a highly sensitive and specific method for
differentiation of ischemia region, prediction of periprocedural myonecrosis and future
adverse cardiac events.
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Background: Final kissing balloon dilatation (FKBD) is a recommended final step in case
of treatment of bifurcation lesions by two stents approaches. Furthermore, dilatation of the side
branch (SB) may be necessary following main vessel (MV) stenting. Occasionally, recrossing
the stent struts with a balloon is hampered because the tip hits a stent strut.
Methods: The Glider (TriReme Medical, Pleasanton, CA; Figure) is a dedicated balloon
designed for crossing through struts of deployed stents toward a SB. From October 2010 to
January 2012.
Results: FKBD was attempted in 236 consecutive bifurcation lesions treated in our
Institution. FKBD was successfully performed by conventional balloon catheters in 221
(93.5%) lesions (Conventional group). In the remaining 15 (6.5%) lesions, where a conven-
tional balloon failed to cross the stent strut, the Glider balloon was attempted (Glider group)
(Table). The angle beta (between the axis of the MV after the branch point and the SB axis at
the point of divergence) was wider in the Glider group (8317° versus 6527°; p 0.032).
A trend toward an higher rate of the true bifurcation lesions was observed in the Glider group
(93% versus 70.5%; p  0.07). The Glider balloon successfully crossed through MV stent
struts toward a SB in 12 patients (80%), whereas failed in the remaining 3 patients.
Conventional group Glider group
P(n  221) (n  15)
Vessel treated 0.25
Distal LM 35 (16%) 3 (20%)
LAD-diagonal 132 (59.5%) 8 (53.5%)
LCx-MO 40 (18%) 3 (20%)
PD-PL 14 (6.5%) 1 (6.5%)
Lesion site 0.47
Ostial - -
Proximal 101(45.5%) 7 (47%)
Middle 65 (29.5%) 4 (26.5%)
Distal 55 (25%) 4 (26.5%)
Reference vessel diameter, mm
Main vessel 3.11  0.51 3.21  0.44 0.59
Side branch 2.10  0.44 2.15  0,45 0.55
Lesion Length, mm
Main vessel 19  8 23  11 0.43
Side branch 64 73 0.88
True bifurcation lesion 156 (70.5%) 14 (93%) 0.07
Bifurcation angle (°)
alpha 153104 11529 0.22
beta 6527 83174 0.032
Diameter stenosis, %
Main vessel 839 8312 0.96
Side branch 5310 5512 0.85
Conclusions: The Glider balloon represents an unique bail-out device which offers an
effective rescue strategy for recrossing stent struts during complex bifurcation stenting.
TCT-677
Use Of Troponin To Diagnose Peri-procedural Myocardial Infarction: Effect
On Composite Endpoints In The British Bifurcation Coronary Study (BBC
ONE)
JAMES COCKBURN1, Miles Behan2, Nick Curzen3, Adam de Belder4,
David Hildick-Smith5, Keith Oldroyd6, Rodney Stables7
1SUSSEX CARDIAC CENTRE, BRIGHTON, United Kingdom, 2Royal Infirmary of
Edinburgh, Edinburgh, Edinburgh, 3Southampton University, Southampton, United
Kingdom, 4Sussex Cardiac Centre, Brighton, UK, Brighton, United Kingdom,
5Royal Sussex County Hospital, Brighton, United Kingdom, 6University of
Glasgow, Glasgow, United Kingdom, 7Liverpool Heart and Chest Hospital NHS
Foundation Trust, Liverpool, Liverpool
Background: Peri-procedural myocardial infarction (PMI, ESC/ACC type 4a) is
diagnosed on the basis of elevation of cardiac enzymesmore than three times the 99th
centile upper reference limit. Recent guidelines recommend the use of troponin instead of
creatine kinase (CK) to diagnose PMI, but this assay increases diagnostic sensitivity,
while the clinical significance of small increases in troponin remains undetermined. We
examined the effects of using the new definition on the incidence of a composite endpoint
(previously defined by CK) in acontemporary clinical randomized trial - the BBC ONE
bifurcation coronary stenting trial.
Methods: The BBC ONE trial randomly allocated 500 patients with coronary bifurcation
lesions to either a simple or complex stenting strategy. The composite primary endpoint
(CPEP) included death, MI (PMI	 subsequent MI) and target vessel failure, at 9 months.
Results: In BBC ONE the CPEP occurred in 8% vs15.2% in the simple and complex
groups respectively(HR 2.02 (1.17-3.47), p0.009). This difference was largely driven by
PMI, which occurred in 9 (3.6%) vs28 (11.2%) of patients (HR 3.24, (1.53-6.86),
p0.001).Using troponin, PMI would have occurred in 71 (28.4%) vs 114 (45.6%)
patients respectively (HR 1.61, (1.27-2.05), p0.001), and the CPEP in 32% vs 48% of
patients (HR 1.50, (1.2-1.87), p0.001). Use of troponin increased myocardial infarction
detection fivefold, from 7.4% to 37.0% overall.
Conclusions: Use of troponin would have led to a fivefold increase in diagnosis of
periprocedural myocardial infarction in the BBC ONE trial. Incorporation of PMI into a
composite endpoint may no longer be justified in many interventional trials.
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Tryton-Xience for the Treatment of Complex Coronary Bifurcation Lesions:
A Single Center Consecutive Series
Daniela Trabattoni1, piero montorsi1, Franco Fabbiocchi1, Giuseppe Calligaris1,
Alessandro Lualdi1, Luca Grancini1, Stefano Galli1, Paolo Ravagnani1,
Giovanni Teruzzi1, Antonio Bartorelli1
1Centro Cardiologico Monzino, IRCCS, Milan, Italy
Background: The Tryton Side-Branch Stent (Tryton) (Tryton Medical) was designed to
treat complex bifurcation lesions (BL). We evaluated all treated patients with a clinical
and angiographic follow-up at 9 mos.
Methods: Tryton is a balloon-expandable cobalt-chromium bare-metal stent with a distal
zone that scaffolds the side branch (SB), a transition zone designed to accomodate any
ostial anatomy and a proximal zone designed to accomodate a standard stent. Tryton is
deployed with the transition zone at the SB origin with the distal end in the SB and
proximal zone into the main vessel (MV). Appropriately sized Xience Prime (Abbott
Vascular) stents were positioned in the MV with the proximal portion covering the Tryton
and the distal portion extending beyond the SB ostium into the distal MV.
Results: We enrolled one hundred-twenty-three consecutive patients (83% male, mean
age 64.69.6 years) with 125 BL (79 LAD-diagonal, 26 LCx-obtuse marginal, 8
RCA-posterior descending and 12 LM-LAD) and Medina classification showing 1.1.1 in
107, 1.1.0 in 12, 0.1.1 in 8. Lesion angle was  30° in 26,  30° and  45° in 75 and
45° in 24. Additional SB stenting, distal to the Tryton stent, was performed in
48(39%)cases to fully cover the lesion. Final kissing balloon was performed in all cases.
Procedural success was 100%. Postprocedural NSTEMI were observed in 17 (13.8%;
CK-MB3 ULN) pts. No definite stent thrombosis, rePCI, CABG occurred. One cardiac
unwitnessed death occurred 7 days after PCI in a previously large anterior STEMI pt.
Clinical and angiographic follow-up data, currently available in 113 (91%) patients are
shown in the Table.
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